Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2021-05-28
2030-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Disease-syndrome Characteristics of IPF
NCT07178392
Air Pollution and Health of COPD Patients
NCT05076630
Investigation of Chronic Obstructive Pulmonary Disease (COPD) Phenotypes and Endotypes in China
NCT04853225
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-associated COPD
NCT06074042
A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China
NCT02600221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with pneumoconiosis
This group is composed of patients with pneumoconiosis.
No interventions assigned to this group
Dust exposure group
This group is composed of patients exposed to dust.
No interventions assigned to this group
Healthy control group
This group is composed of healthy control subjects.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Has participated in any interventional clinical research
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KaiLuan General Hospital
OTHER
The First Affiliated Hospital of Shanxi Medical University
OTHER
Weifang Respiratory Disease Hospital
UNKNOWN
Hubei Hospital of Traditional Chinese Medicine
OTHER
Hunan Prevention and Treatment Institute for Occupational Diseases, China
UNKNOWN
The first affiliated hospital of chongqing medical and pharmaceutical college
UNKNOWN
Centers for Disease Control and Prevention, China
OTHER_GOV
Shandong Gold Mining Company Occupational Disease Precention Hospital
UNKNOWN
Shandong Province Hospital of occupational diseases
UNKNOWN
The Second Hospital of Heilongjiang Province
UNKNOWN
China-Japan Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dai Huaping
Chief physician
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ChinaJapanFH005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.